These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34212342)

  • 1. Assessment of the performance of the SarQoL
    Geerinck A; Dawson-Hughes B; Beaudart C; Locquet M; Reginster JY; Bruyère O
    Aging Clin Exp Res; 2021 Aug; 33(8):2149-2155. PubMed ID: 34212342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Hungarian Version of the SarQoL® Questionnaire and Its Association with the SARC-F Screening Tool.
    Geerinck A; Demián MB; Beaudart C; Gasparik AI
    J Frailty Aging; 2022; 11(3):267-273. PubMed ID: 35799431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older women.
    Fonfría-Vivas R; Pérez-Ros P; Barrachina-Igual J; Pablos-Monzó A; Martínez-Arnau FM
    Aging Clin Exp Res; 2023 Oct; 35(10):2069-2079. PubMed ID: 37442906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation and validation of the Korean version of the Sarcopenia Quality of Life (SarQoL-K®) questionnaire and applicability with the SARC-F screening tool.
    Yoo JI; Ha YC; Kim M; Seo SH; Kim MJ; Lee GY; Seo YM; Sung C; Park KS
    Qual Life Res; 2021 Feb; 30(2):603-611. PubMed ID: 32914375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SarQoL Questionnaire in Community-Dwelling Older Adults under EWGSOP2 Sarcopenia Diagnosis Algorithm: A New Screening Method?
    Guillamón-Escudero C; Diago-Galmés A; Zuazua Rico D; Maestro-González A; Tenías-Burillo JM; Soriano JM; Fernández-Garrido JJ
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions.
    Beaudart C; Locquet M; Reginster JY; Delandsheere L; Petermans J; Bruyère O
    Aging Clin Exp Res; 2018 Apr; 30(4):307-313. PubMed ID: 29197020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the sarcopenia quality of life (SarQoL) questionnaire in community dwelling outpatient postmenopausal hungarian women.
    Pap Z; Kalabiska I; Balogh Á; Bhattoa HP
    BMC Musculoskelet Disord; 2023 Apr; 24(1):331. PubMed ID: 37106363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARC-F for sarcopenia screening in community-dwelling older adults: Are 3 items enough?
    Yang M; Hu X; Xie L; Zhang L; Zhou J; Lin J; Wang Y; Li Y; Han Z; Zhang D; Zuo Y; Li Y; Wu L
    Medicine (Baltimore); 2018 Jul; 97(30):e11726. PubMed ID: 30045339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric Properties of the Spanish Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia.
    Fábrega-Cuadros R; Martínez-Amat A; Cruz-Díaz D; Aibar-Almazán A; Hita-Contreras F
    Calcif Tissue Int; 2020 Mar; 106(3):274-282. PubMed ID: 31781790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the SarQoL®, a specific health-related quality of life questionnaire for Sarcopenia.
    Beaudart C; Biver E; Reginster JY; Rizzoli R; Rolland Y; Bautmans I; Petermans J; Gillain S; Buckinx F; Dardenne N; Bruyère O
    J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):238-244. PubMed ID: 27897430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Persian version of the sarcopenia-specific quality of life questionnaire (SarQoL
    Mahmoodi M; Hejazi N; Bagheri Z; Nasimi N; Clark CCT; Moosavi M; Dabbaghmanesh MH; Mazloom Z
    Aging Clin Exp Res; 2023 Jan; 35(1):137-145. PubMed ID: 36289155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between the quality of life in sarcopenia measured with the SarQoL® and nutritional status.
    Kim Y; Park KS; Yoo JI
    Health Qual Life Outcomes; 2021 Jan; 19(1):28. PubMed ID: 33482832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Responsiveness of the SarQoL
    Geerinck A; Bruyère O; Locquet M; Reginster JY; Beaudart C
    Adv Ther; 2018 Nov; 35(11):1842-1858. PubMed ID: 30374809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric performance of the Romanian version of the SarQoL®, a health-related quality of life questionnaire for sarcopenia.
    Gasparik AI; Mihai G; Beaudart C; Bruyere O; Pop RM; Reginster JY; Pascanu IM
    Arch Osteoporos; 2017 Nov; 12(1):103. PubMed ID: 29139012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia quality-of-life questionnaire (SarQoL)®: translation, cross-cultural adaptation and validation in Turkish.
    Erdogan T; Eris S; Avci S; Oren MM; Kucukdagli P; Kilic C; Beaudart C; Bruyere O; Karan MA; Bahat G
    Aging Clin Exp Res; 2021 Nov; 33(11):2979-2988. PubMed ID: 33538991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Diagnostic Performance of SARC-F and Its Two Modified Versions (SARC-CalF and SARC-F+EBM) in Community-Dwelling Older Adults from Poland.
    Krzymińska-Siemaszko R; Deskur-Śmielecka E; Kaluźniak-Szymanowska A; Lewandowicz M; Wieczorowska-Tobis K
    Clin Interv Aging; 2020; 15():583-594. PubMed ID: 32425513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Three Screening Methods for Sarcopenia in Community-Dwelling Older Persons.
    Mo YH; Zhong J; Dong X; Su YD; Deng WY; Yao XM; Liu BB; Wang XQ; Wang XH
    J Am Med Dir Assoc; 2021 Apr; 22(4):746-750.e1. PubMed ID: 32669238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire.
    Tsekoura M; Billis E; Gliatis J; Tsepis E; Matzaroglou C; Sakkas GK; Beaudart C; Bruyere O; Tyllianakis M; Panagiotopoulos E
    Disabil Rehabil; 2020 Apr; 42(7):1006-1012. PubMed ID: 30453790
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance of the SarQoL quality of life tool in a UK population of older people with probable sarcopenia and implications for use in clinical trials: findings from the SarcNet registry.
    Witham MD; Heslop P; Dodds RM; Clegg AP; Hope SV; McDonald C; Smithard D; Storey B; Tan AL; Thornhill A; Sayer AA
    BMC Geriatr; 2022 Apr; 22(1):368. PubMed ID: 35477354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation and Validation of the Spanish Version of the SARC-F Questionnaire to Assess Sarcopenia in Older People.
    Sánchez-Rodríguez D; Marco E; Dávalos-Yerovi V; López-Escobar J; Messaggi-Sartor M; Barrera C; Ronquillo-Moreno N; Vázquez-Ibar O; Calle A; Inzitari M; Piotrowicz K; Duran X; Escalada F; Muniesa JM; Duarte E
    J Nutr Health Aging; 2019; 23(6):518-524. PubMed ID: 31233072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.